|
1.
|
D Lloyd-JonesRJ AdamsTM BrownExecutive
summary: heart disease and stroke statistics - 2010 update: a
report from the American Heart
AssociationCirculation121948954201010.1161/CIRCULATIONAHA.109.19266620177011
|
|
2.
|
JA ZivinFactors determining the
therapeutic window for
strokeNeurology50599603199810.1212/WNL.50.3.5999521242
|
|
3.
|
AG SorensenWA CopenL OstergaardHyperacute
stroke: simultaneous measurement of relative cerebral blood volume,
relative cerebral blood flow, and mean tissue transit
timeRadiology210519527199910207439
|
|
4.
|
F GonnerL RemondaH MattleLocal
intra-arterial thrombolysis in acute ischemic
strokeStroke2918941900199810.1161/01.STR.29.9.18949731615
|
|
5.
|
SG RichardsonKB MatthewsJ StuartAM
GeddesRM WilcoxSerial changes in coagulation and viscosity during
sickle-cell crisisBr J
Haematol4195103197910.1111/j.1365-2141.1979.tb03685.x420740
|
|
6.
|
SH SukRL SaccoB Boden-AlbalaAbdominal
obesity and risk of ischemic stroke: the Northern Manhattan Stroke
StudyStroke3415861592200310.1161/01.STR.0000075294.98582.2F12775882
|
|
7.
|
Y WinterS RohrmannJ LinseisenContribution
of obesity and abdominal fat mass to risk of stroke and transient
ischemic
attacksStroke3931453151200810.1161/STROKEAHA.108.52300118703800
|
|
8.
|
AR FolsomML RasmussenLE
ChamblessProspective associations of fasting insulin, body fat
distribution, and diabetes with risk of ischemic stroke. The
Atherosclerosis Risk in Communities (ARIC) Study
InvestigatorsDiabetes
Care2210771083199910.2337/diacare.22.7.107710388971
|
|
9.
|
J CastilloR LeiraMM GarciaBlood pressure
decrease during the acute phase of ischemic stroke is associated
with brain injury and poor stroke
outcomeStroke35520526200410.1161/01.STR.0000109769.22917.B014726553
|
|
10.
|
AW Weverling-RijnsburgerIJ JonkersE van
ExelJ GusseklooRG WestendorpHigh-density vs low-density lipoprotein
cholesterol as the risk factor for coronary artery disease and
stroke in old ageArch Intern
Med16315491554200310.1001/archinte.163.13.154912860577
|
|
11.
|
RX YouAG ThriftJJ McNeilSM DavisGA
DonnanIschemic stroke risk and passive exposure to spouses’
cigarette smoking. Melbourne Stroke Risk Factor Study (MERFS)
GroupAm J Public Health895725751999
|
|
12.
|
DW NebertDW RussellClinical importance of
the cytochromes
P450Lancet36011551162200210.1016/S0140-6736(02)11203-712387968
|
|
13.
|
XQ PanYH ZhangYY LiuWJ TongInteraction
between the C(−344)T polymorphism of CYP11B2 and alcohol
consumption on the risk of essential hypertension in a Chinese
Mongolian populationEur J Epidemiol258138212010
|
|
14.
|
X PanY LiuY ZhangInteraction of the C-344T
polymorphism of CYP11b2 gene with body mass index and waist
circumference affecting diastolic blood pressure in Chinese
Mongolian populationBlood
Press19373379201010.3109/08037051.2010.49585920560800
|
|
15.
|
C LiuH LiQ QiCommon variants in or near
FGF5, CYP17A1 and MTHFR genes are associated with blood pressure
and hypertension in Chinese HansJ
Hypertens297075201010.1097/HJH.0b013e32833f60ab20852445
|
|
16.
|
H SchunkertIR KonigS KathiresanLarge-scale
association analysis identifies 13 new susceptibility loci for
coronary artery diseaseNat
Genet43333338201010.1038/ng.78421378990
|
|
17.
|
ZH YuanQ LiuY ZhangCYP2B6 gene single
nucleotide polymorphisms and leukemia susceptibilityAnn
Hematol90293299201010.1007/s00277-010-1085-z20878158
|
|
18.
|
HZ RingAM ValdesDM NishitaGene-gene
interactions between CYP2B6 and CYP2A6 in nicotine
metabolismPharmacogenet
Genomics1710071015200710.1097/01.fpc.0000220560.59972.3318004205
|
|
19.
|
M SamardzijaE TopicM StefanovicAssociation
of CYP2C9 gene polymorphism with bleeding as a complication of
warfarin therapyColl Antropol32557564200818756910
|
|
20.
|
T YinK MaekawaK KamideGenetic variations
of CYP2C9 in 724 Japanese individuals and their impact on the
antihypertensive effects of losartanHypertens
Res3115491557200810.1291/hypres.31.154918971529
|
|
21.
|
SY EomYW ZhangSH KimInfluence of NQO1,
ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol
drinking on the risk of lung cancer in KoreansCancer Causes
Control20137145200910.1007/s10552-008-9225-718798003
|
|
22.
|
A PoduriM KhullarA BahlYP SharmaKK TalwarA
combination of proatherogenic single-nucleotide polymorphisms is
associated with increased risk of coronary artery disease and
myocardial infarction in Asian IndiansDNA Cell
Biol28451460200910.1089/dna.2009.088719558216
|
|
23.
|
YS WeiY LanLQ MengLG NongThe association
of L-selectin polymorphisms with L-selectin serum levels and risk
of ischemic strokeJ Thromb
Thrombolysis32110115201110.1007/s11239-011-0587-421465128
|
|
24.
|
MY CheongOS BangMH ChaAssociation of the
adiponectin gene variations with risk of ischemic stroke in a
Korean populationYonsei Med
J522025201010.3349/ymj.2011.52.1.2021155030
|
|
25.
|
XL ChenJQ ChengRL ZhangStudy on the
relationship between polymorphism of adiponectin gene and risk of
ischemic stroke among Han population in the Northern parts of
ChinaZhonghua Liu Xing Bing Xue Za Zhi31129132201021215068
|
|
26.
|
A de Paula SabinoDD RibeiroCP
DominguetiPlasminogen activator inhibitor-1 4G/5G promoter
polymorphism and PAI-1 plasma levels in young patients with
ischemic strokeMol Biol Rep3853555360201121373825
|
|
27.
|
J KalitaBI SomarajanB KumarB MittalUK
MisraA study of ACE and ADD1 polymorphism in ischemic and
hemorrhagic strokeClin Chim
Acta412642646201010.1016/j.cca.2010.12.02221194526
|
|
28.
|
B JinHC NiW ShenCytochrome P450 2C19
polymorphism is associated with poor clinical outcomes in coronary
artery disease patients treated with clopidogrelMol Biol
Rep3816971702201010.1007/s11033-010-0282-020845077
|
|
29.
|
C FavaM MontagnanaP AlmgrenThe V433M
variant of the CYP4F2 is associated with ischemic stroke in male
Swedes beyond its effect on blood
pressureHypertension52373380200810.1161/HYPERTENSIONAHA.108.11419918574070
|
|
30.
|
MJ O’DonnellD XavierL LiuRisk factors for
ischaemic and intracerebral haemorrhagic stroke in 22 countries
(the INTERSTROKE study): a case-control
studyLancet376112123201020561675
|
|
31.
|
Y TuG CuiY XuGenetic polymorphism of
CYP11B2 gene and stroke in the Han Chinese population and a
meta-analysisPharmacogenet
Genomics21115120201010.1097/FPC.0b013e3283432a3221228735
|
|
32.
|
NN KumarAV BenjafieldRC LinHaplotype
analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows
association with essential hypertensionJ
Hypertens2113311337200310.1097/00004872-200307000-0002212817181
|
|
33.
|
M MatsubaraT SatoT NishimuraCYP11B2
polymorphisms and home blood pressure in a population-based cohort
in Japanese: the Ohasama studyHypertens
Res2716200410.1291/hypres.27.115055249
|
|
34.
|
LA HowardS MiksysE HoffmannD MashRF
TyndaleBrain CYP2E1 is induced by nicotine and ethanol in rat and
is higher in smokers and alcoholicsBr J
Pharmacol13813761386200310.1038/sj.bjp.070514612711639
|
|
35.
|
NM BelliliL FoucanF FumeronAssociations of
the −344 T>C and the 3097 G>A polymorphisms of CYP11B2 gene
with hypertension, type 2 diabetes, and metabolic syndrome in a
French populationAm J Hypertens236606672010
|
|
36.
|
P RussoF LauriaM Loguercio−344C/T Variant
in the promoter of the aldosterone synthase gene (CYP11B2) is
associated with metabolic syndrome in menAm J
Hypertens202182222007
|
|
37.
|
K RanadeKD WuN RischGenetic variation in
aldosterone synthase predicts plasma glucose levelsProc Natl Acad
Sci USA981321913224200110.1073/pnas.22146709811687612
|
